Using Objective Data in ADHD Medication Titration

Titrating ADHD medication is an iterative process: start a dose, observe response, adjust, repeat. The hardest part is knowing whether an adjustment actually helped — symptom checklists filled out weeks apart are a noisy signal, shaped as much by a good or bad week as by the medication itself.

Photo by Vitaly Gariev on Unsplash

The case for repeat measurement

Administering a CPT before starting treatment, and again at each dose adjustment, gives you a baseline and a trend line instead of a single snapshot. Comparing omission errors, commission errors, and reaction-time variability across sessions can help answer a specific clinical question: is attention and impulse control measurably improving, staying flat, or getting worse, alongside what the patient and family are reporting.

Practical considerations

A few things make repeat CPT data more useful in practice:

• Consistent test conditions. Testing at a similar time of day and interval after the last dose reduces noise unrelated to the medication itself.
• Enough spacing between tests. Re-testing too frequently can introduce practice effects that look like improvement but aren’t.
• Reading trends, not single scores. A single session is a data point; the trend across two or three sessions is the signal.

Combining objective and subjective data

Objective CPT data doesn’t replace clinical judgment or patient/family-reported outcomes — it adds a third, harder-to-game input alongside them. When all three point the same direction, that’s a stronger basis for a titration decision than any one alone. Repeat measures at each dose change also strengthen the record behind a PA renewal; see our stimulant prior authorization checklist. For a platform-by-platform budget, see the cost of repeat CPT testing during titration. For the timing question — on medication or off, and how long after a dose change to retest — see when to retest: timing a CPT around stimulant dosing.